Concepedia

Kimberley Jackson

KJ

Statistics

Publications

22

Citations

2.7K

H-Index

17

Active since

2000

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

Clinical Nutrition Research Centre

National University of Singapore

The University of Texas MD Anderson Cancer Center

Kimberley Jackson is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and clinical pharmacology.

ORCID

Publications per year

2000–2024

22

Publications

22

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Sandeep T. Patil, Lu Zhang, Ferenc Martényi et al. · Nature Medicine · 2007 · 1K citations

, , +12

Neutrophil elastase inhibition in acute lung injury: Results of the STRIVE study

Bernhardt Zeiher, Antonio Artigas, Jean‐Louis Vincent et al. · Critical Care Medicine · 2004 · 347 citations

, , +13

A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

Bruce J. Kinon, Lu Zhang, Brian A. Millen et al. · Journal of Clinical Psychopharmacology · 2011 · 257 citations

, , +17

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Natalia Lapteva, April Durett, Jiali Sun et al. · Cytotherapy · 2012 · 208 citations · Full text

, , +16

Drug–excipient interactions and their affect on absorption

Kimberley Jackson, David Young, Sonia Pant · Pharmaceutical Science & Technology Today · 2000 · 100 citations

, , +12

1–5 of 22